Literature DB >> 24989607

Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification.

Maria Homs1, Katja Giersch2, Maria Blasi1, Marc Lütgehetmann2, Maria Buti3, Rafael Esteban3, Maura Dandri2, Francisco Rodriguez-Frias4.   

Abstract

Hepatitis D virus (HDV) is a defective RNA virus that requires the surface antigens of hepatitis B virus (HBV) (HBsAg) for viral assembly and replication. Several commercial and in-house techniques have been described for HDV RNA quantification, but the methodologies differ widely, making a comparison of the results between studies difficult. In this study, a full-length genomic RNA standard was developed and used for HDV quantification by two different real-time PCR approaches (fluorescence resonance energy transfer [FRET] and TaqMan probes). Three experiments were performed. First, the stability of the standard was determined by analyzing the effect of thawing and freezing. Second, because of the strong internal base pairing of the HDV genome, which leads to a rod-like structure, the effect of intense thermal shock (95°C for 10 min and immediate cooling to -80°C) was tested to confirm the importance of this treatment in the reverse transcription step. Lastly, to investigate the differences between the DNA and RNA standards, the two types were quantified in parallel with the following results: the full-length genomic RNA standard was stable and reliably mimicked the behavior of HDV-RNA-positive samples, thermal shock enhanced the sensitivity of HDV RNA quantification, and the DNA standard underquantified the HDV RNA standard. These findings indicate the importance of using complete full-length genomic RNA and a strong thermal-shock step for optimal HDV RNA quantification.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24989607      PMCID: PMC4313150          DOI: 10.1128/JCM.00940-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.

Authors:  Melanie Schaper; Francisco Rodriguez-Frias; Rosendo Jardi; David Tabernero; Maria Homs; Gerardo Ruiz; Josep Quer; Rafael Esteban; Maria Buti
Journal:  J Hepatol       Date:  2010-03-05       Impact factor: 25.083

2.  Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA.

Authors:  Caroline Scholtes; Vinca Icard; Majid Amiri; Philippe Chevallier-Queyron; Mary-Anne Trabaud; Christophe Ramière; Fabien Zoulim; Patrice André; Paul Dény
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

3.  Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard.

Authors:  R B Ferns; E Nastouli; J A Garson
Journal:  J Virol Methods       Date:  2011-11-15       Impact factor: 2.014

4.  Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study.

Authors:  M Buti; M Homs; F Rodriguez-Frias; G Funalleras; R Jardí; S Sauleda; D Tabernero; M Schaper; R Esteban
Journal:  J Viral Hepat       Date:  2011-06       Impact factor: 3.728

5.  Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population.

Authors:  Dazhuang Shang; Sarah A Hughes; Mary Horner; Matthew J Bruce; Yan Dong; Ivana Carey; Abid R Suddle; Kosh Agarwal; Phillip M Harrison; Mark Atkins
Journal:  J Virol Methods       Date:  2012-05-18       Impact factor: 2.014

Review 6.  An update on HDV: virology, pathogenesis and treatment.

Authors:  Mónica V Alvarado-Mora; Stephen Locarnini; Mario Rizzetto; João R Rebello Pinho
Journal:  Antivir Ther       Date:  2013-06-21

Review 7.  Hepatitis D virus: an update.

Authors:  Stéphanie Pascarella; Francesco Negro
Journal:  Liver Int       Date:  2010-09-29       Impact factor: 5.828

8.  Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis.

Authors:  Joerg Hofmann; Katrin Frenzel; Bui Q Minh; Arndt von Haeseler; Anke Edelmann; Stefan R Ross; Thomas Berg; Detlev H Krüger; Helga Meisel
Journal:  Diagn Microbiol Infect Dis       Date:  2010-06       Impact factor: 2.803

9.  Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D.

Authors:  A Katsoulidou; E Manesis; C Rokka; C Issaris; A Pagoni; V Sypsa; A Hatzakis
Journal:  J Viral Hepat       Date:  2012-09-13       Impact factor: 3.728

10.  Commercial real-time reverse transcriptase PCR assays can underestimate or fail to quantify hepatitis delta virus viremia.

Authors:  Ségolène Brichler; Frédéric Le Gal; Afifaa Butt; Sylvie Chevret; Emmanuel Gordien
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-01       Impact factor: 11.382

View more
  2 in total

1.  Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.

Authors:  Christine Y L Tham; Janine Kah; Anthony T Tan; Tassilo Volz; Adeline Chia; Katja Giersch; Yvonne Ladiges; Alessandro Loglio; Marta Borghi; Camille Sureau; Pietro Lampertico; Marc Lütgehetmann; Maura Dandri; Antonio Bertoletti
Journal:  Cell Rep Med       Date:  2020-07-21

2.  Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection.

Authors:  Maria Homs; Francisco Rodriguez-Frias; Josep Gregori; Alicia Ruiz; Pilar Reimundo; Rosario Casillas; David Tabernero; Cristina Godoy; Salma Barakat; Josep Quer; Mar Riveiro-Barciela; Michael Roggendorf; Rafael Esteban; Maria Buti
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.